Maine Medicaid and tirzepatide
Zepbound for weight loss: no. Listed only under sleep apnea. Requires moderate to severe sleep apnea confirmed by a sleep study, with prior authorization, BMI 30 or higher. Mounjaro for weight loss: unclear. The MaineCare PDL says weight loss drugs are not covered, but that general line does not name this drug and the PDL gives no drug-specific limit for it. Mounjaro is not on the 10/9/2026 PDL at all, though the 10/1/2025 PDL listed it as non-preferred.; for type 2 diabetes Maine Medicaid must cover it. Read from Maine Department of Health and Human Services, Office of MaineCare Services documents Nov 6, 2026.
In 2025 Maine Medicaid paid for 5,336 tirzepatide prescriptions (Mounjaro, Zepbound), 13% of its GLP-1 prescriptions and 42nd of the 50 states and DC. It reimbursed $4.9 million before rebates, $927 a prescription against $1,032 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Mounjaro | 4,578 | $4.4 million | $964 |
| Zepbound | 758 | $536,383 | $708 |
Maine plans and prescribing rules
State of Maine Health Plan. Since July 1, 2026 the State of Maine Health Plan covers GLP-1s for weight loss only for members enrolled in Virta Health who get the prescription from a Virta provider. Existing users had to be enrolled with Virta by October 30, 2026 to keep coverage.
Tirzepatide in the states around Maine
| State | Sell tirzepatide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Zepbound for weight loss |
|---|---|---|---|---|
| Maine | 17 | $69/moWellmedr | 5,336 | Medicaid Zepbound: No |
| New Hampshire | 17 | $69/moWellmedr | 9,302 | Medicaid Zepbound: No |
| Vermont | 17 | $69/moWellmedr | 2,783 | Medicaid Zepbound: No |
| Massachusetts | 16 | $69/moWellmedr | 269,389 | Medicaid Zepbound: No |



